• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Kawasaki Disease Complicated With Macrophage Activation Syndrome: Case Reports and Literature Review.川崎病合并巨噬细胞活化综合征:病例报告及文献综述
Front Pediatr. 2019 Nov 1;7:423. doi: 10.3389/fped.2019.00423. eCollection 2019.
2
Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches.川崎病患儿巨噬细胞活化综合征:诊断与治疗方法。
World J Pediatr. 2020 Dec;16(6):566-574. doi: 10.1007/s12519-020-00360-6. Epub 2020 May 16.
3
Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report.一名5个月大男童患川崎病休克综合征并发巨噬细胞活化综合征:病例报告
Medicine (Baltimore). 2019 Jan;98(4):e14203. doi: 10.1097/MD.0000000000014203.
4
Kawasaki disease complicated with shock syndrome, macrophage activation syndrome, and acute abdomen in children: Two case reports.川崎病合并儿童休克综合征、巨噬细胞活化综合征及急腹症:两例报告
Front Pediatr. 2023 Apr 21;11:1152242. doi: 10.3389/fped.2023.1152242. eCollection 2023.
5
Atypical Kawasaki Disease Complicated With Coronary Artery Aneurysm: A Case Report and Review of Literature.非典型川崎病合并冠状动脉瘤:一例报告并文献复习
Cureus. 2021 Feb 27;13(2):e13589. doi: 10.7759/cureus.13589.
6
Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.川崎病合并巨噬细胞活化综合征:一项系统评价
J Pediatr Hematol Oncol. 2017 Aug;39(6):445-451. doi: 10.1097/MPH.0000000000000872.
7
Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome?患有川崎病且持续发热的儿童有患巨噬细胞活化综合征的风险吗?
Pediatrics. 2003 Dec;112(6 Pt 1):e495. doi: 10.1542/peds.112.6.e495.
8
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉瘤的预测因素
Paediatr Int Child Health. 2018 Aug;38(3):209-212. doi: 10.1080/20469047.2018.1471381. Epub 2018 May 17.
9
An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children.川崎病非典型表现报告及静脉注射免疫球蛋白无反应儿童识别的最新进展
Diagnostics (Basel). 2023 Apr 17;13(8):1441. doi: 10.3390/diagnostics13081441.
10
[Clinical analysis of 942 cases of Kawasaki disease].942例川崎病临床分析
Zhonghua Er Ke Za Zhi. 2006 May;44(5):324-8.

引用本文的文献

1
Macrophage Activation Syndrome in Kawasaki Disease: Insights from a Systematic Literature Review on Diagnosis, Clinical Features, and Treatment.川崎病中的巨噬细胞活化综合征:关于诊断、临床特征及治疗的系统文献综述见解
Children (Basel). 2025 Mar 11;12(3):349. doi: 10.3390/children12030349.
2
Atypical Kawasaki disease with giant coronary artery aneurysms in a 2-month-old boy: a case report.一名2个月大男婴患非典型川崎病并伴有巨大冠状动脉瘤:病例报告
J Med Case Rep. 2024 Dec 20;18(1):630. doi: 10.1186/s13256-024-04987-1.
3
Kawasaki Disease-Associated Cytokine Storm Syndrome.川崎病相关细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:365-383. doi: 10.1007/978-3-031-59815-9_25.
4
Heterogeneity of macrophage activation syndrome and treatment progression.巨噬细胞活化综合征的异质性和治疗进展。
Front Immunol. 2024 Apr 26;15:1389710. doi: 10.3389/fimmu.2024.1389710. eCollection 2024.
5
[Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].川崎病合并巨噬细胞活化综合征的临床特征:27例分析
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jun 15;25(6):572-578. doi: 10.7499/j.issn.1008-8830.2302015.
6
Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome.阿那白滞素对一名复发性川崎病合并巨噬细胞活化综合征婴儿多发冠状动脉瘤的疗效
Children (Basel). 2022 May 5;9(5):672. doi: 10.3390/children9050672.
7
Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.川崎病糖皮质激素应用的儿科专家共识
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Mar 15;24(3):225-231. doi: 10.7499/j.issn.1008-8830.2112033.
8
Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease.全身免疫炎症指数对川崎病静脉注射免疫球蛋白抵抗及心血管并发症的预测价值
Front Cardiovasc Med. 2021 Aug 24;8:711007. doi: 10.3389/fcvm.2021.711007. eCollection 2021.
9
Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis - Two Ends of the Same Spectrum.川崎病与全身型幼年特发性关节炎——同一谱系的两端。
Front Pediatr. 2021 Apr 28;9:665815. doi: 10.3389/fped.2021.665815. eCollection 2021.
10
Importance of Serum Ferritin Level for Early Diagnosis and Differentiation in Patients with Kawasaki Disease with Macrophage Activation Syndrome.血清铁蛋白水平在川崎病合并巨噬细胞活化综合征患者早期诊断及鉴别诊断中的重要性
Children (Basel). 2021 Mar 31;8(4):269. doi: 10.3390/children8040269.

本文引用的文献

1
Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.静脉注射免疫球蛋白单独使用及静脉注射免疫球蛋白联合大剂量阿司匹林在川崎病急性期的疗效:一项随机对照试验的研究方案
BMC Pediatr. 2018 Jun 22;18(1):200. doi: 10.1186/s12887-018-1180-1.
2
Preventing coronary artery lesions in Kawasaki disease.预防川崎病中的冠状动脉病变。
Biomed J. 2017 Jun;40(3):141-146. doi: 10.1016/j.bj.2017.04.002. Epub 2017 May 30.
3
Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.川崎病合并巨噬细胞活化综合征:一项系统评价
J Pediatr Hematol Oncol. 2017 Aug;39(6):445-451. doi: 10.1097/MPH.0000000000000872.
4
Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker.川崎病中的贫血:铁调素作为一种潜在的生物标志物
Int J Mol Sci. 2017 Apr 12;18(4):820. doi: 10.3390/ijms18040820.
5
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
6
Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital.川崎病患儿的特征:三级儿科医院 10 年的经验。
J Microbiol Immunol Infect. 2018 Apr;51(2):184-190. doi: 10.1016/j.jmii.2016.06.004. Epub 2016 Jul 29.
7
Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?2016年巨噬细胞活化综合征的标准是否应适用于川崎病以及全身型幼年特发性关节炎患儿?
Ann Rheum Dis. 2016 Jul;75(7):e44. doi: 10.1136/annrheumdis-2016-209395. Epub 2016 Mar 10.
8
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.2016 年巨噬细胞活化综合征合并全身型幼年特发性关节炎分类标准:欧洲抗风湿病联盟/美国风湿病学会/儿科风湿病国际研究组织合作倡议
Ann Rheum Dis. 2016 Mar;75(3):481-9. doi: 10.1136/annrheumdis-2015-208982.
9
Macrophage activation syndrome in Kawasaki disease: more common than we thought?川崎病中的巨噬细胞活化综合征:比我们想象的更常见?
Semin Arthritis Rheum. 2015 Feb;44(4):405-10. doi: 10.1016/j.semarthrit.2014.07.007. Epub 2014 Aug 7.
10
Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.成人反应性噬血细胞综合征:162 例回顾性分析。
Am J Med. 2014 Nov;127(11):1118-1125. doi: 10.1016/j.amjmed.2014.04.034. Epub 2014 May 14.

川崎病合并巨噬细胞活化综合征:病例报告及文献综述

Kawasaki Disease Complicated With Macrophage Activation Syndrome: Case Reports and Literature Review.

作者信息

Jin Ping, Luo Yong, Liu Xi, Xu Jinji, Liu Chunyi

机构信息

Pediatric Intensive Care Unit, Baoan Maternal and Child Health Hospital, College of Medicine, Jinan University, Shenzhen, China.

Department of Cardiology, Baoan Maternal and Child Health Hospital, College of Medicine, Jinan University, Shenzhen, China.

出版信息

Front Pediatr. 2019 Nov 1;7:423. doi: 10.3389/fped.2019.00423. eCollection 2019.

DOI:10.3389/fped.2019.00423
PMID:31737585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6838014/
Abstract

Macrophage activation syndrome (MAS) is a rare and severe complication of Kawasaki disease (KD). The clinical feature, early diagnosis and treatment options, and prognosis need to be further determined in patients with KD complicated with MAS. In this report, we retrospectively analyzed three KD patients complicated with MAS who were treated in pediatric intensive care units (PICU) and reviewed the relevant literatures. We find that being male, being age over 2 years old, incomplete KD, intravenous immunoglobulin (IVIG) non-responder, or persistent fever greater than 10 days are all highly associated with occurrence of MAS. Additional work-ups should be performed promptly in patient with above predisposing factors to rule out complication of MAS. Patients with KD complicated with MAS are at a higher risk of having coronary artery involvement or aneurysm formation, which can be reversed with timely treatment. Early identification and prompt treatment are key points for improving the prognosis of KD patients complicated with MAS.

摘要

巨噬细胞活化综合征(MAS)是川崎病(KD)一种罕见且严重的并发症。KD合并MAS患者的临床特征、早期诊断与治疗方案以及预后仍需进一步明确。在本报告中,我们回顾性分析了在儿科重症监护病房(PICU)接受治疗的3例KD合并MAS患者,并复习了相关文献。我们发现,男性、年龄大于2岁、不完全KD、静脉注射免疫球蛋白(IVIG)无反应者或持续发热超过10天均与MAS的发生高度相关。对于有上述易感因素的患者,应及时进行进一步检查以排除MAS并发症。KD合并MAS患者发生冠状动脉受累或动脉瘤形成的风险更高,及时治疗可使其逆转。早期识别和及时治疗是改善KD合并MAS患者预后的关键。